Beyond CD19: Engineering next-generation CAR-T cell therapies for leukemia
Current Molecular Pharmacology · 2026 · 19 (1) · 319-352
DOI: 10.1016/j.cmp.2026.09.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Molecular Pharmacology, 2026. Verfasst von Tejveer Singh und 8 weiteren Autor:innen. Die Arbeit nennt 300 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Indian Council of Medical Research, Research and Development, Central Council for Research in Homeopathy, Ministry of AYUSH, Government of India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Indian Council of Medical Research
- Research and Development
- Central Council for Research in Homeopathy, Ministry of AYUSH, Government of India
Zitieren
APA
Singh, T., Jain, A., Bohot, M., Tuli, H. S., Banerjee, S., Barbalho, S. M., Direito, R., Casarcia, N., & Bishayee, A. (2026). Beyond CD19: Engineering next-generation CAR-T cell therapies for leukemia. Current Molecular Pharmacology, 19(1), 319-352. https://doi.org/10.1016/j.cmp.2026.09.006
Vancouver
Singh T, Jain A, Bohot M, Tuli HS, Banerjee S, Barbalho SM, et al. Beyond CD19: Engineering next-generation CAR-T cell therapies for leukemia. Current Molecular Pharmacology. 2026;19(1):319-352. doi:10.1016/j.cmp.2026.09.006
BibTeX
@article{Singh2026,
author = {Singh, Tejveer and Jain, Aadipoojya and Bohot, Monica and Tuli, Hardeep Singh and Banerjee, Sabyasachi and Barbalho, Sandra Maria and Direito, Rosa and Casarcia, Nicolette and Bishayee, Anupam},
title = {Beyond CD19: Engineering next-generation CAR-T cell therapies for leukemia},
journal = {Current Molecular Pharmacology},
year = {2026},
volume = {19},
number = {1},
pages = {319--352},
doi = {10.1016/j.cmp.2026.09.006}
}
EUVIMED